The Court of Appeals case involved the criminal conviction of a pharma sales rep, Alfred Caronia, for conspiracy to introduce a misbranded drug into interstate commerce in violation of the Federal Drug and Cosmetic Act.
The subsidiary, EndoVascular Technologies, "also agreed to plead guilty to ten felony counts, including nine for shipping misbranded products and one count of a former employee making false statements to the government, " Guidant said in a statement.